🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12323+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12323 recruiting trials

Phase 1, PHASE2RecruitingNCT06242379

Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa

👨‍⚕️ Laongsri Atchaneeyasakul, Professor, Mahidol University📍 1 site📅 Started May 2024View details ↗
Phase 2RecruitingNCT05977673

Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy

👨‍⚕️ Pier Luigi Zinzani, MD, Istituto di Ematologia "L. e A. Seràgnoli", AOU Policlinico S.Orsola-Malpighi, Bologna📍 10 sites📅 Started May 2024View details ↗
Phase 3RecruitingNCT06351631

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

👨‍⚕️ Medical Director, Merck Sharp and Dohme LLC📍 21 sites📅 Started May 2024View details ↗
Phase 2RecruitingNCT06569485

A Study of Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma Patients

🏥 Sun Yat-sen University📍 1 site📅 Started May 2024View details ↗
NARecruitingNCT06413069

Effects of Almonds in Glucose-intolerant Adults (AGAMEMNON)

🏥 Charite University, Berlin, Germany📍 1 site📅 Started May 2024View details ↗
Phase 1, PHASE2RecruitingNCT06421519

Different Levels of BiPAP

👨‍⚕️ Theodore Dassios, King's College Hospital NHS Trust📍 1 site📅 Started May 2024View details ↗
NARecruitingNCT06352242

Is Trogocytosis a Predictive Marker of CAR-T Cell Response in Diffuse Large B-cell Lymphoma?

👨‍⚕️ Ludovic GABELLIER, MD, Montpellier University Hospital📍 2 sites📅 Started May 2024View details ↗
Phase 2RecruitingNCT06532084

Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen

🏥 St. Petersburg State Pavlov Medical University📍 1 site📅 Started May 2024View details ↗
NARecruitingNCT06399822

Impact of Capillaroscopy on the Management of Undifferentiated Connective Tissue Disease

👨‍⚕️ Laetitia Michou, MD PhD, CHU de Quebec (Université Laval)📍 1 site📅 Started May 2024View details ↗
Phase 1, PHASE2RecruitingNCT06235801

A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia

👨‍⚕️ Nicholas Short, MD, MD Anderson Center📍 1 site📅 Started May 2024View details ↗
Phase 1RecruitingNCT06451497

Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors

👨‍⚕️ Maloy Ghosh, PhD, Zumutor Biologics Inc.📍 3 sites📅 Started May 2024View details ↗
Phase 2RecruitingNCT06055621

Evaluation of DASATINIB Monotherapy Efficacy in Acute Myeloid Leukemia Patients Refractory to VENETOCLAX-AZACITIDINE

🏥 Institut Paoli-Calmettes📍 1 site📅 Started May 2024View details ↗
NARecruitingNCT06528639

A Clinical Study on Exercise Guided by CPET to Reduce the Risk of Metabolic Cardiovascular Diseases(C-MET Trial)

👨‍⚕️ Yi-Da Tang, MD, PhD, Peking University Third Hospital📍 1 site📅 Started May 2024View details ↗
Phase 3RecruitingNCT06133972

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 127 sites📅 Started May 2024View details ↗
Phase 2RecruitingNCT06430788

A Study of Emapalumab for Pediatric Aplastic Anemia

👨‍⚕️ Andromachi Scaradavou, MD, Memorial Sloan Kettering Cancer Center📍 6 sites📅 Started May 2024View details ↗
NARecruitingNCT06575218

The Effectiveness of Virtual Reality Training Program

🏥 Yeditepe University📍 1 site📅 Started May 2024View details ↗
EARLY_Phase 1RecruitingNCT06511752

Educational Support Group Program for Bilingual and Spanish-speaking Carepartners and People With Progressive Aphasia

🏥 University of Texas at Austin📍 1 site📅 Started May 2024View details ↗
Phase 1RecruitingNCT06374485

Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment

🏥 Lee's Pharmaceutical Limited📍 1 site📅 Started May 2024View details ↗
NARecruitingNCT06247150

Tissue Immune Landscape of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation (TIL-GVHD)

🏥 University Hospital, Bordeaux📍 1 site📅 Started May 2024View details ↗
NARecruitingNCT06481020

Plant Sterols on Cardiovascular Markers, Microbiota and Sterol Metabolism (Cardiofoodsterol)

👨‍⚕️ Guadalupe Garcia Llatas, Professor, University of Valencia📍 1 site📅 Started May 2024View details ↗
← PreviousPage 292 of 617Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →